From: Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China
 |  | ESCC | GCA | GNCA | |||
---|---|---|---|---|---|---|---|
FH | Control (%) | Case (%) | OR (95% CI) | Case (%) | OR (95% CI) | Case (%) | OR (95% CI) |
Any malignant tumor | Â | Â | Â | Â | Â | Â | Â |
First degree relative | 334(22) | 197(33) | 1.72(1.39–2.12) | 162(27) | 1.32(1.06–1.64) | 94(30) | 1.52(1.15–1.99) |
1 affected | 294(19) | 160(27) | 1.58(1.26–1.98) | 135(22) | 1.25(0.99–1.58) | 79(25) | 1.43(1.07–1.92) |
≥ 2 affected | 40(3) | 37(6) | 2.76(1.73–4.40) | 27(5) | 1.83(1.10–3.03) | 15(5) | 2.15(1.16–3.98) |
P trend | Â | Â | <0.001 | Â | 0.005 | Â | 0.001 |
Male | 233(21) | 126(34) | 2.00(1.50–2.54) | 132(27) | 1.35(1.05–1.73) | 78(33) | 1.83(1.34–2.49) |
Female | 101(25) | 71(32) | 1.40(0.98–2.02) | 30(28) | 1.24(0.76–2.01) | 16(21) | 0.81(0.44–1.48) |
< 50 yr | 59(22) | 41(38) | 2.17(1.32–3.56) | 22(33) | 1.95(1.06–3.58) | 28(36) | 2.39(1.35–4.25) |
≥ 50 yr | 275(22) | 156(32) | 1.61(1.27–2.04) | 140(26) | 1.25(0.98–1.58) | 66(28) | 1.35(0.98–1.85) |
Non-blood relative | 58(4) | 26(4) | 1.08(0.66–1.76) | 25(4) | 1.02(0.62–1.66) | 6(2) | 0.61(0.26–1.46) |
Any UGI cancer | Â | Â | Â | Â | Â | Â | Â |
First degree relative | 170(11) | 131(22) | 2.28(1.77–2.95) | 104(17) | 1.62(1.24–2.12) | 53(17) | 1.65(1.17–2.33) |
1 affected | 162(11) | 114(19) | 2.08(1.59–2.71) | 88(15) | 1.43(1.08–1.90) | 46(14) | 1.50(1.05–2.15) |
≥ 2 affected | 8(1) | 17(3) | 6.37(2.82–15.6) | 16(3) | 5.35(2.26–12.7) | 7(2) | 4.78(1.68–13.6) |
P trend | Â | Â | <0.001 | Â | <0.001 | Â | 0.001 |
Male | 124(11) | 88(23) | 2.59(1.90–3.54) | 87(18) | 1.66(1.23–2.23) | 45(19) | 1.89(1.29–2.77) |
Female | 46(11) | 43(19) | 1.85(1.16–2.92) | 17(16) | 1.52(0.82–2.80) | 8(10) | 0.98(0.43–2.20) |
< 50 yr | 34(12) | 23(21) | 1.84(1.01–3.35) | 10(15) | 1.23(0.56–2.68) | 17(22) | 2.34(1.18–4.65) |
≥ 50 yr | 136(11) | 108(22) | 2.37(1.78–3.16) | 94(18) | 1.70(1.28–2.27) | 36(15) | 1.51(1.01–2.26) |
Non-blood relative | 26(2) | 12(2) | 1.11(0.54–2.24) | 13(2) | 1.17(0.59–2.32) | 3(1) | 0.73(0.22–2.45) |
Esophageal cancer | Â | Â | Â | Â | Â | Â | Â |
First degree relative | 97(6) | 95(16) | 2.84(2.09–3.86) | 52(9) | 1.34(0.94–1.91) | 28(9) | 1.56(0.99–2.43) |
1 affected | 93(6) | 83(14) | 2.53(1.84–3.50) | 43(7) | 1.15(0.79–1.68) | 25(8) | 1.44(0.90–2.30) |
≥ 2 affected | 4(0.3) | 13(2) | 10.0(3.24–31.2) | 9(2) | 5.75(1.74–19.0) | 3(1) | 4.54(0.96–21.6) |
P trend | Â | Â | <0.001 | Â | 0.022 | Â | 0.026 |
Father | 52(3) | 40(7) | 2.01(1.31–3.10) | 23(4) | 1.06(0.64–1.76) | 13(4) | 1.27(0.68–2.38) |
Mother | 29(2) | 34(6) | 3.27(1.96–5.47) | 19(3) | 1.69(0.93–3.07) | 14(4) | 2.52(1.30–4.89) |
Sibling | 21(1) | 35(6) | 4.66(2.67–8.13) | 20(3) | 2.36(1.26–4.41) | 4(1) | 1.14(0.38–3.40) |
Non-blood relative | 9(0.6) | 7(1) | 1.86(0.68–5.10) | 6(1) | 1.49(0.52–4.26) | 1(0.3) | 0.76(0.09–6.16) |
Gastric cardia cancer | 25(2) | 23(4) | 2.45(1.37–4.39) | 28(5) | 2.87(1.65–5.00) | 12(4) | 2.35(1.16–4.79) |
Gastric noncardia cancer | 51(3) | 19(3) | 0.95(0.56–1.64) | 31(5) | 1.54(0.97–2.44) | 17(5) | 1.52(0.86–2.69) |
Any non- UGI tumor | Â | Â | Â | Â | Â | Â | Â |
First degree relative | 164(11) | 66(11) | 0.98(0.72–1.33) | 58(10) | 0.92(0.67–1.27) | 41(13) | 1.22(0.84–1.76) |
Non-blood relative | 32(2) | 14(2) | 1.05(0.55–2.01) | 12(2) | 0.90(0.46–1.77) | 3(1) | 0.54(0.16–1.80) |